1. Shapiro, J, van Lanschot, JJB, Hulshof, MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 2015; 16: 1090–1098.
Google Scholar | Crossref | Medline | ISI2. Yang, H, Liu, H, Chen, Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol 2018; 36: 2796–2803.
Google Scholar | Crossref | Medline3. Rice, TW, Chen, LQ, Hofstetter, WL, et al. Worldwide Esophageal Cancer Collaboration: pathologic staging data. Dis Esophagus 2016; 29: 724–733.
Google Scholar | Crossref | Medline4. Rice, TW, Ishwaran, H, Hofstetter, WL, et al. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus 2016; 29: 897–905.
Google Scholar | Crossref | Medline5. National Comprehensive Cancer Network : NCCN Clinical Practice guidelines in oncology: esophageal and esophagogastric junction cancers version 2 2020, https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf
Google Scholar6. Lerut, T, Nafteux, P, Moons, J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 2004; 240: 962–974.
Google Scholar | Crossref | Medline7. Nakagawa, S, Kanda, T, Kosugi, SI, et al. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 2004; 198: 205–211.
Google Scholar | Crossref | Medline | ISI8. Hsu, PK, Huang, CS, Wu, YC, et al. Open versus thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma. World J Surg 2014; 38: 402–409.
Google Scholar | Crossref | Medline | ISI9. Mariette, C, Balon, JM, Piessen, G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer-Am Cancer Soc 2003; 97: 1616–1623.
Google Scholar | Crossref | Medline10. Liu, Q, Cai, XW, Wu, B, et al. Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy. PLoS ONE 2014; 9: e0097225.
Google Scholar11. Parry, K, Visser, E, van Rossum, PS, et al. Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent. Ann Surg Oncol 2015; 22: S1292–S1300.
Google Scholar | Crossref | Medline12. Blom, RL, Lagarde, SM, Oudenaarde, K, et al. Survival after recurrent esophageal carcinoma has not improved over the past 18 years. Ann Surg Oncol 2013; 20: 2693–2698.
Google Scholar | Crossref | Medline13. Su, X-D, Zhang, D-K, Zhang, X, et al. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma. J Thorac Dis 2014; 6: 949–957.
Google Scholar | Medline14. Peyre, CG, Hagen, JA, DeMeester, SR, et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy a multinational study on the significance of the number of involved lymph nodes. Ann Surg 2008; 248: 979–985.
Google Scholar | Crossref | Medline15. Shim, YM, Kim, HK, Kim, K. Comparison of survival and recurrence pattern between two-field and three-field lymph node dissections for upper thoracic esophageal squamous cell carcinoma. J Thorac Oncol 2010; 5: 707–712.
Google Scholar | Crossref | Medline16. Weiser, MR, Landmann, RG, Kattan, MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol 2008; 26: 380–385.
Google Scholar | Crossref | Medline17. Sweldens, C, Peeters, S, van Limbergen, E, et al. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram. Cancer J 2014; 20: 1–7.
Google Scholar | Crossref | Medline18. Zhang, WY, Chen, XX, Chen, WH, et al. Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy. BMC Cancer 2018; 18: 1–8.
Google Scholar | Crossref | Medline19. Xiao, ZF, Yang, ZY, Liang, J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003; 75: 331–336.
Google Scholar | Crossref | Medline | ISI20. Chen, J, Liu, S, Pan, J, et al. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg 2009; 36: 480–486.
Google Scholar | Crossref | Medline21. Chen, J, Zhu, J, Pan, J, et al. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus. Ann Thorac Surg 2010; 90: 435–442.
Google Scholar | Crossref | Medline22. Xu, S, Ross, C, Raebel, MA, et al. Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health 2010; 13: 273–277.
Google Scholar | Crossref | Medline | ISI23. Lerut, T, Moons, J, Coosemans, W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg 2009; 250: 798–807.
Google Scholar | Crossref | Medline24. Tanaka, H, Ohira, M, Kubo, N, et al. Association of location of lymph node metastases with postoperative recurrence of esophageal squamous cell carcinoma. Anticancer Res 2012; 32: 3421–3426.
Google Scholar | Medline25. Situ, D, Wang, J, Lin, P, et al. Do tumor location and grade affect survival in pT3N0M0 esophageal squamous cell carcinoma. ? J Thorac Cardiovasc Surg 2013; 146: 45–51.
Google Scholar | Crossref | Medline26. Hsu, PK, Wang, BY, Huang, CS, et al. Prognostic Factors for Post-recurrence Survival in Esophageal Squamous Cell Carcinoma Patients with Recurrence after Resection. J Gastrointest Surg 2011; 15: 558–565.
Google Scholar | Crossref | Medline27. Yi, M, Meric-Bernstam, F, Kuerer, HM, et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 2012; 30: 600–607.
Google Scholar | Crossref | Medline28. Werkhoven, E, Van Hart, G, Tinteren, H, et al. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiother Oncol 2011; 100: 101–107.
Google Scholar | Crossref | Medline29. Rodrigues, G, Warner, A, Zindler, J, et al. A clinical nomogram and recursive partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain metastases. Radiother Oncol 2014; 111: 52–58.
Google Scholar | Crossref | Medline30. Jones, GD, Brandt, WS, Shen, R, et al. A genomic-pathologic annotated risk model to predict recurrence in early-stage lung adenocarcinoma. JAMA Surg 2020; 156: e205601.
Google Scholar | Crossref31. Deng, W, Yang, J, Ni, W, et al. Postoperative radiotherapy in pathological T2–3N0M0 thoracic esophageal squamous cell carcinoma: interim report of a prospective, phase III, randomized controlled study. Oncologist 2020; 25: e701–e708.
Google Scholar | Crossref | Medline32. Yu, S, Zhang, W, Ni, W, et al. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy. Radiother Oncol 2019; 140: 159–166.
Google Scholar | Crossref | Medline33. Zhang, W, Liu, XX, Xiao, Z, et al. Postoperative intensity-modulated radiotherapy improved survival in lymph node-positive or stage III thoracic esophageal squamous cell carcinoma. Oncol Res Treat 2015; 38: 97–102.
Google Scholar | Crossref | Medline34. Chen, J, Pan, J, Zheng, X, et al. Number and location of positive nodes, postoperative radiotherapy, and survival after Esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012; 82: 475–482.
Google Scholar | Crossref | Medline35. Xiao, ZF, Yang, ZY, Miao, YJ, et al. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys 2005; 62: 82–90.
Google Scholar | Crossref | Medline | ISI36. Kang, J, Chang, JY, Sun, X, et al. Role of postoperative concurrent chemoradiotherapy for esophageal carcinoma: a meta-analysis of 2165 patients. J Cancer 2018; 9: 584–593.
Google Scholar | Crossref | Medline37. Kelly, RJ, Ajani, JA, Kuzdzal, J, et al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med 2021; 384: 1191–1203.
Google Scholar | Crossref | Medline38. Patel, K, Askari, A, Moorthy, K. Long-term oncological outcomes following completely minimally invasive esophagectomy versus open esophagectomy. Dis Esophagus off J Int Soc Dis Esophagus 2020; 33: 1–10.
Google Scholar